Oaktree Acquisition Corp. III Life Sciences (OACC) Operating Expenses (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Operating Expenses readings, the most recent being $456538.0 for Q1 2026.
- Quarterly Operating Expenses rose 2.64% to $456538.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, changed N/A year-over-year, with the annual reading at $1.2 million for FY2025, 239.87% up from the prior year.
- Operating Expenses hit $456538.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $255496.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $456538.0 in Q1 2026 and bottomed at $225579.0 in Q3 2025.